BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

722 related articles for article (PubMed ID: 24299176)

  • 1. Fluorine in pharmaceutical industry: fluorine-containing drugs introduced to the market in the last decade (2001-2011).
    Wang J; Sánchez-Roselló M; Aceña JL; del Pozo C; Sorochinsky AE; Fustero S; Soloshonok VA; Liu H
    Chem Rev; 2014 Feb; 114(4):2432-506. PubMed ID: 24299176
    [No Abstract]   [Full Text] [Related]  

  • 2. Application of Fluorine in Drug Design During 2010-2015 Years: A Mini-Review.
    Wang BC; Wang LJ; Jiang B; Wang SY; Wu N; Li XQ; Shi DY
    Mini Rev Med Chem; 2017; 17(8):683-692. PubMed ID: 26471967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based organic synthesis of drug prototypes: a personal odyssey.
    Hanessian S
    ChemMedChem; 2006 Dec; 1(12):1301-30. PubMed ID: 17091524
    [No Abstract]   [Full Text] [Related]  

  • 4. Phytochemical and biological studies of Lycium medicinal plants.
    Yao X; Peng Y; Xu LJ; Li L; Wu QL; Xiao PG
    Chem Biodivers; 2011 Jun; 8(6):976-1010. PubMed ID: 21674776
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthetic Approaches to the New Drugs Approved During 2015.
    Flick AC; Ding HX; Leverett CA; Kyne RE; Liu KK; Fink SJ; O'Donnell CJ
    J Med Chem; 2017 Aug; 60(15):6480-6515. PubMed ID: 28421763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic Approaches to the New Drugs Approved During 2017.
    Flick AC; Leverett CA; Ding HX; McInturff E; Fink SJ; Helal CJ; O'Donnell CJ
    J Med Chem; 2019 Aug; 62(16):7340-7382. PubMed ID: 30939001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applications of asymmetric organocatalysis in medicinal chemistry.
    Alemán J; Cabrera S
    Chem Soc Rev; 2013 Jan; 42(2):774-93. PubMed ID: 23154582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrazole containing natural products: synthetic preview and biological significance.
    Kumar V; Kaur K; Gupta GK; Sharma AK
    Eur J Med Chem; 2013 Nov; 69():735-53. PubMed ID: 24099993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-Thiazolidinones: the advances continue….
    Tripathi AC; Gupta SJ; Fatima GN; Sonar PK; Verma A; Saraf SK
    Eur J Med Chem; 2014 Jan; 72():52-77. PubMed ID: 24355348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorine in the pharmaceutical industry: Synthetic approaches and application of clinically approved fluorine-enriched anti-infectious medications.
    Niu ZX; Hu J; Sun JF; Wang YT
    Eur J Med Chem; 2024 May; 271():116446. PubMed ID: 38678824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innovative fluorine-addition process could enable faster drug design and manufacture.
    Future Med Chem; 2009 Sep; 1(6):1028. PubMed ID: 21545053
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis and biological evaluation of some novel cyclic-imides as hypoglycaemic, anti-hyperlipidemic agents.
    Abdel-Aziz AA; El-Azab AS; Attia SM; Al-Obaid AM; Al-Omar MA; El-Subbagh HI
    Eur J Med Chem; 2011 Sep; 46(9):4324-9. PubMed ID: 21783284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Progresses in the field of pharmacology. 3].
    Hörig C; Koch H; Mayr E; Selchau M
    Pharmazie; 1971 Sep; 26(9):509-33. PubMed ID: 4944695
    [No Abstract]   [Full Text] [Related]  

  • 14. Data-mining for sulfur and fluorine: an evaluation of pharmaceuticals to reveal opportunities for drug design and discovery.
    Ilardi EA; Vitaku E; Njardarson JT
    J Med Chem; 2014 Apr; 57(7):2832-42. PubMed ID: 24102067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microwave-assisted synthesis, hypolipidemic and hypoglycemic activity of some novel 2-(4-(2-Amino-6-(4-substituted phenyl)-pyrimidin-4-yl)-phenoxy)-2-methyl propanoic acid derivatives.
    Mokale SN; Elgire RD; Sakle NS; Shinde DB
    Arch Pharm (Weinheim); 2012 Jan; 345(1):22-7. PubMed ID: 22076967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of 5-chloro-1-(2,3-dideoxy-3-fluoro-beta-D-glycero-hex-2- enopyranose-4-ulosyl)uracil as potential anticancer/antiviral agent.
    Khan AR; Mulligan KX; Ollapally AP
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):759-62. PubMed ID: 11563110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naturally occurring iridoids and secoiridoids. An updated review, part 4.
    Dinda B; Debnath S; Banik R
    Chem Pharm Bull (Tokyo); 2011; 59(7):803-33. PubMed ID: 21720031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on synthetic and structural characterization of new fluorine substituted phthalides of pharmaceutical interest.
    Chamoli T; Rawat MS; Jacob M
    J Enzyme Inhib Med Chem; 2012 Oct; 27(5):748-57. PubMed ID: 21919700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NME digest.
    Drug News Perspect; 2005 Apr; 18(3):190-6. PubMed ID: 15931713
    [No Abstract]   [Full Text] [Related]  

  • 20. Current and future impact of green chemistry on the pharmaceutical industry.
    Fortunak JM
    Future Med Chem; 2009 Jul; 1(4):571-5. PubMed ID: 21426025
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 37.